Background: Trichorhinophalangeal syndrome (TRPS) patients tend to have alopecia that appears to be androgenetic, and this genetic model might give clues to the pathogenesis of hair loss or hair morphogenesis. Objective: This study was conducted to identify additional genetic evidence of TRPS and hair morphogenesis from a TRPS patient. Methods: From one TRPS type I patient, we extracted RNA and profiled whole transcriptome in non-balding and balding scalp areas using high-throughput RNA sequencing. Results: We found a total of 26,320 genes, which comprised 14,892 known genes with new isoforms and 4,883 novel genes from the non-balding and balding areas. Among these, a total of 1,242 genes showed different expression in the two scalp areas (p＜0.05 and log2 fold-change ＞0). Several genes related to the skin and hair, alopecia, and the TRPS1 gene were validated by qRT-PCR. Twelve of 15 genes (KRT6C, KRTAP3-1, MKI67, GPRC5D, TYRP1, DSC1, PMEL, WIF1, SOX21, TINAG, PTGDS, and TRPS1) were down-regulated (10 genes: p＜0.01; SOX21 and PTGDS: p＞0.05), and the three other genes (HBA2, GAL, and DES) were up-regulated (p ＜0.01) in the balding scalp. Many genes related to keratin and hair development were down-regulated in the balding scalp of the TRPS type I patient. In particular, the TRPS1 gene might be related to androgen metabolism and hair morphogenesis. Conclusion: Our result could suggest a novel perspective and evidence to support further study of TRPS and hair morphogenesis. (Ann Dermatol 29 (5) 
INTRODUCTION
Type I trichorhinophalangeal syndrome (TRPS) presents with craniofacial dysmorphism, skeletal abnormality, and sparse scalp hairs 1 . TRPS patients tend to have alopecia that appears to be androgenetic, and thus, this genetic model might give clues to the pathogenesis of hair loss or hair morphogenesis, as has been found in previous studies 2 . Fantauzzo and Christiano 1 reported that the target genes of Trps1, Wif1, Sox18, and Sox21 played an important role in vibrissa follicle morphogenesis by analyzing the gene expression profiles between wild-type and Trps1Δgt/Δgt mutant mouse embryos to understand hair morphogenesis. This is very interesting because sparse scalp hair is a common feature of TRPS. Herein, we analyzed whole transcriptome from non-balding and balding scalp areas from the TRPS patient using high-throughput sequencing and attempted to identify important genetic information about TRPS symptoms and hair morphogenesis. 
MATERIALS AND METHODS

Information of patient with TRPS type I
A 15-year-old boy visited with sparse and slowly growing scalp hairs that had been that way since his childhood. Especially, his fronto-temporal hair line regressed to the vertex and his vertex hair density and thickness decreased compared to the occiput hairs. He had the typical TRPS phenotypes, including a bulbous nose, a long philtrum, and abnormally short fingers and toes. We took tissue from the non-balding (occiput area) and balding portions (vertex area) of his scalp for genetic analysis ( Supplementary  Fig. 1 ). This study was approved by the institutional review board of Dankook University Hospital (IRB no. DKUH 2014-08-005).
RNA sequencing
We extracted total RNA from the tissues using trizol reagent, and then enriched mRNA by oligo-dT and synthesized to cDNA. We subjected the cDNA to end-repair and poly-A addition and connected it with 5' and 3'adaptors on both ends 3 . By separating on a BluePippin 2% agarose gel (Sage Science, Beverly, MA, USA), we selected and amplified suitable fragments. The final library sizes and qualities were evaluated with an Agilent High Sensitivity DNA kit (Agilent Technologies, Santa Clara, CA, USA). Subsequently, we performed high-throughput RNA sequencing using an Illumina Hiseq2500 sequencer (Illumina, San Diego, CA, USA). Among total output reads, we mapped high-quality reads to the human reference genome (Ensembl release 72) 4 .
Differentially expressed genes and gene ontology analysis We calculated the gene expression level based on fragments per kilobase of exon per million mapped reads (FPKM) using Cufflinks v2.1.13 from Ensembl release 72. We generated gene-level count data using HTSeq-count v0.5.4p3 5 . Based on this, we analyzed differentially expressed genes (DEGs) using the gene TCC 6 . We calculated normalization factors using iterative DEGES/edgeR. We fil- Quantitative real-time polymerase chain reaction
We synthesized a total of 500 ng of RNA to cDNA using M-MLV reverse transcriptase (Promega, Madison, WI, USA) and an RNase inhibitor (Promega). We designed a primer pair for target genes using Primer 3 (http://bioinfo. ut.ee/primer3-0.4.0/primer3/) (Supplementary Table 1) .
We amplified 15 genes and a GAPDH gene as a control to normalize expression using the Eco Real-Time PCR System (Illumina). We confirmed the absence of any nonspecific amplified products through melting curve analysis at 55 o C∼95 o C. All reactions were performed in triplicate and analyzed by delta-delta Ct method.
RESULTS
Dataset from RNA sequencing
We processed a total of ten billion raw reads in the filtering step and mapped 94.9% and 94.8% of the clean reads on the human reference genome (Table 1) . Based on these data, we found a total of 26,320 genes, which comprised 14,892 known genes with new isoforms and 4,883 novel genes. At the transcript level, we found a total of 218,609 transcripts expressed (FPKM ＞0) in either the non-balding and balding scalps.
Identifying differentially expressed genes
Based on FPKM value, we analyzed gene expression levels and identified DEGs between the non-balding and balding scalp samples. The total number of DEGs was 1,242, comprising transcripts expressed in both samples and in either sample (with p-value ＜0.05 and log2
fold-change ＞0) (Fig. 1 ). Compared to non-balding sample, up-and down-regulated genes were 636 and 606 in balding scalp; specifically, 557 genes showed sample-specific expression. 10 .
Though the correlation of TRPS1 gene and androgen metabolism has not yet been studied in the alopecia, we could expect the further study about this correlation because the male pattern baldness is associated with androgen metabolism.
WIF1 and SOX21, the target genes of TRPS1, were down-regulated in a TRPS1Δgt/Δgt mutant mouse and in the balding scalp of a TRPS type I patient 1 . WIF1 is a Wnt inhibitor and is expressed in dermal papilla, like TRPS1
gene. In a previous study, Wnt-related genes including WNT11 and WIF1 were up-regulated in a 120-day-old goat embryo in which secondary hair follicles and mature primary hair follicles were present, which indicates that Wnt signaling is involved in early hair follicle formation 11 .
The SOX21 gene was shown to regulate the layered differentiation of hair follicles 12 . Its disruption showed the human alopecia-like phenotype in a mouse with progressive hair loss. Interestingly, target gene expression in TRPS was not inversely proportional to that in Fantauzzo's TRPS1 Δgt/Δgt mutant mouse 1 .
We compared the gene expression patterns with those of androgenetic alopecia by Garza et al.
13
. KRT6C and GPRC5D were down-regulated and the HBA2 gene was up-regulated in balding scalp in both studies. However, PTGDS expression was not significant, unlike in a previous study 13 . The GPRC5D gene was dramatically up-regulated in hair follicle keratinization and differentiation in the skin of an old embryo (120-day) in which secondary hair follicles had developed and primary hair follicles had matured, indicating its role in keratinization and hair follicle morphogenesis 11 . PTGDS might be involved in androgenetic alopecia 13 , but it is not related to hair loss in TRPS.
In conclusion, we expect our results to suggest novel perspectives and support further study to understand TRPS and hair morphogenesis. Biological_ process
Mitotic cell cycle Progression through the phases of the mitotic cell cycle, the most common eukaryotic cell cycle, which canonically comprises four successive phases called G1, S, G2, and M and includes replication of the genome and the subsequent segregation of chromosomes into daughter cells. In some variant cell cycles nuclear replication or nuclear division may not be followed by cell division, or G1 and G2 phases may be absent. 
Multicellular organismal development
The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
GO:00 07405
Biological _process
Neuroblast proliferation
The expansion of a neuroblast population by cell division. A neuroblast is any cell that will divide and give rise to a neuron.
GO:00 07442
Hindgut morphogenesis
The process in which the anatomical structures of the hindgut are generated and organized.
GO:00 08202
Steroid metabolic process The chemical reactions and pathways involving steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
GO:00 08544
Epidermis development
The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of a plant or animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.
GO:009888
Tissue development
The process whose specific outcome is the progression of a tissue over time, from its formation to the mature structure.
GO:00 10976
Positive regulation of neuron projection development Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). Biological _process
Hair follicle morphogenesis The process in which the anatomical structures of the hair follicle are generated and organized.
GO:00 32502
Developmental process A biological process whose specific outcome is the progression of an integrated living unit: an anatomical structure (which may be a subcellular structure, cell, tissue, or organ), or organism over time from an initial condition to a later condition. Hair cycle The cyclical phases of growth (anagen), regression (catagen), quiescence (telogen), and shedding (exogen) in the life of a hair; one of the collection or mass of filaments growing from the skin of an animal, and forming a covering for a part of the head or for any part or the whole of the body.
GO:042640
Anagen
The growth phase of the hair cycle. Lasts, for example, about 3 to 6 years for human scalp hair.
GO:00 43588
Skin development
The process whose specific outcome is the progression of the skin over time, from its formation to the mature structure. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner vascular dermis (cutis, corium or true skin) composed mostly of connective tissue. The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome. 
Respiratory chain
The protein complexes that form the electron transport system (the respiratory chain), associated with a cell membrane, usually the plasma membrane (in prokaryotes) or the inner mitochondrial membrane (on eukaryotes). The respiratory chain complexes transfer electrons from an electron donor to an electron acceptor and are associated with a proton pump to create a transmembrane electrochemical gradient. The lipid bilayer surrounding an alveolar lamellar body, a specialized secretory organelle found in type II pneumocytes and involved in the synthesis, secretion, and reutilization of pulmonary surfactant.
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